Merz Pharmaceuticals offers $22 a share for Obagi (OMPI) and trumps Valeant's (VRX) bid of...

|About: Obagi Medical Products, Inc. (OMPI)|By:, SA News Editor

Merz Pharmaceuticals offers $22 a share for Obagi (OMPI) and trumps Valeant's (VRX) bid of $19.75 , which valued Obagi at $360M. Merz says it has the money to pay for the deal and doesn't need to carry out further due diligence, as it was already in talks to buy Obagi when the Valeant deal was announced. Obagi surges 15.2% to $22.70.